Directors’ Trades: A $2.7 million buy into South African manganese and sales after exercising options
Link copied to
This fortnight’s recap of ASX directors trades included a number of sales following exercising of options and a $2.7 million buy into a South African focused manganese play
Jupiter Mines (ASX:JMS) director Brian Gilbertson bought $2.7 million in his company’s shares in an off market trade.
Manganese is the fourth-most-traded metal in the world, only trailing aluminium, iron ore and copper, and Jupiter has the largest single manganese mine in South Africa.
Production saw a slight fall in the most recent half year due to the impacts of COVID-19 and softening of manganese prices.
|RID||Ridley Corporation||Michael McMahon||Buy||6 November||300,000||$250,740||On market|
|IDX||Integral Diagnostics||Chien Ho||Sell||6 November||60,000||$265,500||On market|
|WAF||West African Resources||Richard Hyde||Sell||9 November||2,000,000||$2,000,000||On market|
|JMS||Jupiter Mines||Brian Gilbertson||Buy||9 November||10,000,000||$2,700,000||On market|
|MNB||Minbos Resources||Peter Wall||Buy||6 November||66,666,667||$100,000||Placement|
|EOS||Electro Optic Systems||Ian Dennis||Sell||9 November||25,000||$147,353||On market|
|DEG||De Grey Mining||Peter Hood||Buy||3 November||300,000||$360,000||Placement|
|RMY||RMA Global||David Williams||Buy||29 October||545,452||$120,000||Share Purchase Plan|
|CFO||CFOAM||Gary Steineperis||Buy||16 November||16,860,208||$252,903||Rights Issue|
|ACF||Acrow Formwork & Construction Services||Peter Lancken||Buy||13 November||328,577||$113,162||Dividend Reinvestment Plan|
|HLA||Healthia||Glen Richards||Buy||10 November||1,261,333||$1,198,266||Rights Issue|
|ACF||Acrow Formwork & Construction||Margaret Prokop||Buy||13 November||326,937||$112,597||Dividend Reinvestment Plan|
|HLA||Healthia||Paul Wilson||Buy||10 November||870,499||$826,974||Rights Issue|
|TYR||Tyro Payments||David Fite||Sell||10 November||120,000||$498,000||On market|
|CPT||CPT Global||Gerard Tuddenham||Buy||16 November||742,837||$148,567||Dividend Reinvestment Plan|
|WWG||Wiseway Group||Florence & Roger Tong||Buy||16 November||672,634||$162,926||On market|
|LTR||Liontown Resources||David Richards||Sell||12 November||1,300,000||$328,179||On market|
|TNT||Tesserent||Kurt Hansen||Buy||17 November||1,592,112||$593,062||On market|
|MDR||MedAdvisor||Joshua Swinnerton||Buy||18 November||526,316||$200,000||Rights Issue|
Next up was Healthia (ASX:HLA) which is a “roll up” of multiple allied health businesses.
Healthia director Glen Richards bought nearly $1.2 million while his colleague Paul Wilson chipped in over $800,000 – both in a rights issue.
Peter Hood, from the biggest gold success story of 2020, De Grey (ASX:DEG), bought $360,000 in the company’s most recent placement.
Another successful industry has been cybersecurity, and the success story within that success story has been Tesserent (ASX:TNT). Kurt Hansen bought just over $593,000 on market.
The company says the study met its objectives and is now eyeing commercialisation.
CFOAM (ASX:CFO), a company that makes carbon foam products from coal, saw Gary Steineperis chip in just over $250,000.
A high proportion of sellers this week sold shares after exercising options and consequently having to pay a tax bill.
The biggest sale came from was Richard Hyde of West African Resources (ASX:WAF), who parted with $2 million in shares.
Selling on market without exercising options were David Fite of fintech payments platform Tyro (ASX:TYR), who parted with $498,000 of shares while Integral Diagnostics’ (ASX:IDX) Chien Ho parted with $265,600.